A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors
Clinical trial NCT06895928 · RECRUITING
Trial details
- NCT number
- NCT06895928
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-28
- Primary completion
- 2028-12-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.